Dr. Szabo earned his PhD in Neurosciences from McGill University, Montreal, Quebec, Canada. He subsequently completed postdoctoral trainings in Psychopharmacology at the University of Florida, Department of Psychiatry, and in the Mood and Anxiety Disorders Program at the National Institutes of Mental Health (NIMH). This allowed him to detail the mechanism of action of mood stabilizers and agents like ketamine on the glutamate system. Dr. Szabo later completed medical school and prior to embarking on psychiatry residency at Duke University in 2009, he participated in the Summers of Discovery Program at the National Institutes of Environmental Health Sciences (NIEHS) to investigate environmental causes of mood dysregulation. Dr. Szabo has been practicing psychiatry for nearly 10 years and is a Board-Certified Psychiatrist. He has published more than 50 scientific papers in peer-reviewed journals.